Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals (ICPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,503,519
  • Shares Outstanding, K 32,943
  • Annual Sales, $ 252,000 K
  • Annual Income, $ -344,680 K
  • 60-Month Beta 1.78
  • Price/Sales 6.10
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -2.91
  • Number of Estimates 11
  • High Estimate -2.20
  • Low Estimate -3.17
  • Prior Year -2.28
  • Growth Rate Est. (year over year) -27.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.19 +8.18%
on 07/14/20
49.38 -7.57%
on 07/20/20
-2.27 (-4.74%)
since 06/30/20
3-Month
42.19 +8.18%
on 07/14/20
95.98 -52.45%
on 05/12/20
-36.28 (-44.29%)
since 04/30/20
52-Week
42.19 +8.18%
on 07/14/20
125.00 -63.49%
on 12/31/19
-18.34 (-28.67%)
since 07/30/19

Most Recent Stories

More News
Biotech Stock Roundup: GILD Prices Remdesivir, VXRT Rises, ICPT Plunges & More

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline developments.

ALXN : 102.49 (-2.21%)
GILD : 69.53 (-3.87%)
VRTX : 272.00 (-2.65%)
ZGNX : 23.79 (-2.30%)
ICPT : 45.64 (-2.27%)
VXRT : 9.39 (-5.34%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or "the Company") (NASDAQ:...

ICPT : 45.64 (-2.27%)
Intercept Slumps as the FDA Issues CRL to NASH Candidate

Intercept (ICPT) down on receipt of CRL for its NDA seeking approval of OCA for the treatment of fibrosis due to nonalcoholic steatohepatitis (NASH).

VKTX : 7.02 (-6.90%)
GLMD : 4.85 (-0.41%)
ICPT : 45.64 (-2.27%)
GNFT : 4.91 (+2.51%)
Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

ICPT : 45.64 (-2.27%)
Watch for Intercept Pharma to Potentially Pullback After Gaining 2.25% Yesterday

Intercept Pharma (NASDAQ:ICPT) traded in a range yesterday that spanned from a low of $81.02 to a high of $83.57. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high...

ICPT : 45.64 (-2.27%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT

Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT). Such investors are advised to contact Robert S. Willoughby...

ICPT : 45.64 (-2.27%)
7.3% Return Seen to Date on SmarTrend Intercept Pharma Call (ICPT)

SmarTrend identified a Downtrend for Intercept Pharma (NASDAQ:ICPT) on May 22nd, 2020 at $78.97. In approximately 3 weeks, Intercept Pharma has returned 7.31% as of today's recent price of $73.19.

ICPT : 45.64 (-2.27%)
Why Is Intercept (ICPT) Down 9.4% Since Last Earnings Report?

Intercept (ICPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ICPT : 45.64 (-2.27%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT

Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT). Such investors are advised to contact Robert S. Willoughby...

ICPT : 45.64 (-2.27%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT

Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT). Such investors are advised to contact Robert S. Willoughby...

ICPT : 45.64 (-2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ICPT with:

Business Summary

Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company's lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR)....

See More

Key Turning Points

2nd Resistance Point 48.70
1st Resistance Point 47.17
Last Price 45.64
1st Support Level 44.64
2nd Support Level 43.64

See More

52-Week High 125.00
Fibonacci 61.8% 93.37
Fibonacci 50% 83.60
Fibonacci 38.2% 73.82
Last Price 45.64
52-Week Low 42.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar